6,7-Dimethoxy-N-(4-phenoxyphenyl)-

6,7-Dimethoxy-N-(4-phenoxyphenyl)-
  • CAS No.:179248-59-0

Important Notice

  1. This product is a chemical product/pharmaceutical intermediate. It is not a drug, an active pharmaceutical ingredient (API), or a pharmaceutical-grade material. It has not been granted a drug approval number or a Chemical Drug Substance Approval Notice, has not passed drug-related review and approval, and is not manufactured, tested, or released in accordance with pharmaceutical GMP.
  2. This product is intended solely for non-clinical research, process development, quality studies, further chemical processing, or chemical synthesis. It must not be used in drug-product manufacturing, clinical trials, clinical diagnosis, or administration to humans or animals, or be sold, used as an input, submitted for regulatory filing, or released as an API or pharmaceutical material.
  3. The purchaser must not use this product, or supply it to another party, for personal consumption, sports or fitness, weight loss, health supplements, food, or animal feed.
Other grades of this product :
6,7-Dimethoxy-N-(4-phenoxyphenyl)- Basic information
Product Name:6,7-Dimethoxy-N-(4-phenoxyphenyl)-
Synonyms:6,7-Dimethoxy-N-(4-phenoxyphenyl)-;Src I1;SKI-1;Src Inhibitor-1;Src-l1;ANTI-HHAT (N-TERM) antibody produced in rabbit;HHAT;MART2
CAS:179248-59-0
MF:C22H19N3O3
MW:373.4
EINECS:
Product Categories:Amines;Aromatics;Heterocycles;Inhibitors
Mol File:179248-59-0.mol
6,7-Dimethoxy-N-(4-phenoxyphenyl)- Chemical Properties
storage temp. 2-8°C
solubility DMSO: >10mg/mL
form white powder
color White or off-white
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 week.
Safety Information
Hazard Codes Xn
Risk Statements 22-36/37/38
Safety Statements 26
RIDADR UN 3077 9 / PGIII
WGK Germany 3
MSDS Information
6,7-Dimethoxy-N-(4-phenoxyphenyl)- Usage And Synthesis
DescriptionSrc-I1 (179248-59-0) is a potent and competitive dual site (ATP- and peptide-binding) Src kinase inhibitor (IC50‘s = 44 nM for Src and 88 nM for Lck). Src-I1 also inhibits VEGFR2 (IC50 = 320 nM).
UsesSrc Kinase inhibitor 1 lung cancers with EGF receptor abnormalities and is a potential candidate for mol.-targeted therapy
UsesSrc Inhibitor-1 may be used in Src kinase-mediated cell signaling studies.
General DescriptionA potent, selective, dual site, cell-permeable, reversible and ATP-competitive inhibitor of Src tyrosine kinase (IC50 = 44 nM and 88 nM for Src and Lck, respectively). Shown to simultaneously interact with both the ATP- and peptide-binding sites. Inhibits VEGFR2 and c-fms tyrosine kinases only at higher concentrations (IC50 = 320 nM and 30 μM, respectively).
Biochem/physiol ActionsCell permeable: yes
References1) Tian et al. (2001) Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines; Biochem. 40 7084 2) Bain et al. (2007) The selectivity of protein kinase inhibitors: a further update; Biochem. J. 408 297
6,7-Dimethoxy-N-(4-phenoxyphenyl)- Preparation Products And Raw materials

Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Read the full Disclaimer
Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye